Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’m shocked that the price is still at 0.50.. what is going on?!
As a very long term investor, this is huge. I feel like we will finally get our answer soon enough. A conclusion and decision seems to finally be coming!
Honestly, I invested in this when in school. Been averaging down at cheap shares and really just forget about it. I view this board a few times a month, but this stock is a gamble for sure. I was here for the Neil woodford days all the way till now. It seems that we are finally inching towards a conclusion. MHA approval or rejection.
Yeah. I’ve been in this for almost a decade now. At this point, you have to just let it ride. Management has always sucked at communicating
Great point George.
For us longs, this certainly feels like a shifting of the tide!
Perhaps we get some financing news later today?
Hit 0.94
We just got two PRs in the past month or so.. can’t complain too much especially with the past
If they announce partnership with combination trials, that would be HUGE
Down two pennies? No way this ends red
So any news from today? Weird it’s so quiet
Is NWBO doing anything at ASCO?
Did we ever find out who loaned the three million to the company?
We just need to hope for a buyout.
Took 2,000 myself!
Is Linda L speaking Sunday for only ten minutes with the trial presentation or is there more?
Is his talk being taped? When is this coming
Is NWBO presenting at 3 PM today? I can’t find anything on ASCO about their session
Looking very good so far
Hmm I see. Thanks
I can agree with this, however the change reflects that the FDA accepted the endpoints right? As long as they accepted, the path to approvable remains viable
Looks like we hit bottom!
Something tells me this isn’t from the Sunday articles released. Was there a financing? This is dropping horrendously
Agreed. This is terrible to watch. I bought average shares at 1.12 last week. Horrible decision
Yep. This is sad
You would think so… Company Communication has always been weak.
I doubt there will be a BO. I remember shareholders asking for a BO during a previous ASM. LP reply was something along the lines of I don’t think shareholders would be happy with the offer price or something. I’m sure someone can cite more evidence with this, but it was posted on iHub several years ago.
I think the company is waiting for publication for PRing things
Clearly I didn’t expect a tanking of SP with the news. I would like to get more clarity on SAP approval from regulators. I would hate for them to ask for a confirmatory trial bc they switched SAP after trial began. I cannot think of another drug that was approved when SAP was switched, even though blinded results.
I do think GBM is definitely a disease state that warrants considerable leniency. Overall, I wish I got some at 0.4 but I don’t regret my decisions to add yesterday.
I wish. My average cost from buying yesterday was 1.12 2500 shares
What is missing? More discussion yes, but results are all there no?
TLD? We got the full results today I thought
I listened to the Q and A portion with Marnix. There were several questions wanting to know more about the historical group they used. It’ll be interesting to see where this goes.
Is anyone thinking FDA will not approve based on using Historical Control Group? Or ask for another phase 3 trial?
Looks like 0.78 is going to be the end price today! Not a bad rebound from 0.4
Just bought at 1.205!
Hope you’re right. I’ve seen AF be right too many times. It’ll be justice to see great results tomorrow
Interesting. So after years of silence regarding trial, there now disclosing information? Something seems a bit odd with this. Hope I’m wrong and you’re right though
How is it legal to tell people that data is being presented?